Specification
| Target | CD11a |
| Reactivities | Human |
| Biosimilar | Efabio |
| Isotype | Human IgG1-kappa |
| Property | Antibody |
| Alternative | ;hu1124;CD11 antigen-like family member A; CD11a antigen; CD11a; CD11Aantigen CD11A (p180), lymphocyte function-associated antigen 1, alphapolypeptide; Integrin alpha L; integrin alpha-L; integrin gene promoter; integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen1; alpha polypeptide); ITGAL; Leukocyte adhesion glycoprotein LFA-1 alpha chain; Leukocyte function-associated molecule 1 alpha chain; LFA-1 alpha; LFA-1; LFA1A; LFA-1A; Ly-15; Ly-21; lymphocyte function-associated antigen 1 |
| Recommend Isotype | Anti-HEL Human IgG1-Kappa Isotype control |
| Formulation Buffer | PBS, pH 7.4,Contains no stabilizers or preservatives |
| Recommend Buffer | PBS, pH 7.4,Contains no stabilizers or preservatives. |
| Endotoxin | <1EU/mg Determined by LAL gel clotting assay |
| Purity | >95% Determined by SDS-PAGE |
| Sterility | 0.2 μM filtered |
| Expression Host | CHO |
| Purification method | Protein A |
| Storage | The product should be stored at the original stock concentration at 4°C. Avoid freeze-thaw cycles. |
| Note | Due to the variability in applications, investigators should consult application references to estimate the appropriate dose or concentration. This dose or concentration can then be further optimized through experimental methods such as dose-response or titration experimentsThe sequence of this product comes from:IMGT |
Background
QC Data
| Note | Please contact us for QC Data |
| Product Image (Reference Only) |  |